Susvimo® (ranibizumab injection) is approved to treat people with wet age-related macular degeneration (AMD) who have previously responded to at least 2 anti-vascular endothelial growth factor (VEGF) injections. Susvimo is a 2-part system that includes an eye implant filled with medicine. A doctor places the implant into the eye during a one-time outpatient procedure. The medicine is continuously delivered into the eye through the implant, which is refilled every 6 months . . .
Published in MacularDegeneration.net on May 9, 2022